MS

Martin Sumner-Smith

AB Allelix Biopharmaceuticals: 6 patents #7 of 61Top 15%
1O 1149336 Ontario: 5 patents #4 of 7Top 60%
NP Nps Pharmaceuticals: 2 patents #51 of 103Top 50%
NA Nps Allelix: 1 patents #26 of 40Top 65%
Overall (All Time): #419,974 of 4,157,543Top 15%
12
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
8933039 Glucagon-like peptide-2 analogs Daniel J. Drucker, Anna E. Crivici 2015-01-13
8846625 Glucagon-like peptide-2 analogs Daniel J. Drucker, Anna E. Crivici 2014-09-30
7781401 Glucagon-like peptide-2 analogs Daniel J. Drucker, Anna E. Crivici 2010-08-24
6489295 Antagonists of intestinotrophic GLP-2 peptides Daniel J. Drucker, Anna E. Crivici 2002-12-03
6184201 Intestinotrophic glucagon-like peptide-2 analogs Daniel J. Drucker, Anna E. Crivici 2001-02-06
5994500 Antagonists of intestinotrophic GLP-2 peptides Daniel J. Drucker, Anna E. Crivici 1999-11-30
5831001 Treatment of herpesvirus infection Michael Twist, Richard W. Barnett, Lorne S. Reid 1998-11-03
5789379 Glucagon-like peptide-2 analogs Daniel J. Drucker, Anna E. Crivici 1998-08-04
5789531 Peptide-based inhibitors of HIV replication Richard W. Barnett, Lorne S. Reid, Nahum Sonenberg 1998-08-04
5674849 Anti-viral compositions Michael Twist 1997-10-07
5646120 Peptide-based inhibitors of HIV replication Richard W. Barnett, Lorne S. Reid, Nahum Sonenberg 1997-07-08
5633230 Treatment of cytomegalovirus infection Michael Twist 1997-05-27